+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Age Group, By Infection (COVID-19, Influenza), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 130 Pages
  • July 2023
  • Region: Global
  • Grand View Research
  • ID: 5853876
Description Jump to:
The global respiratory disease vaccine market size is expected to reach USD 70.30 billion by 2030, expanding at a CAGR of 1.21% from 2023 to 2030. The growth of the respiratory disease vaccine market is attributable to increasing awareness associated with the importance of vaccination, the rising incidence of respiratory infections, and advancements in vaccine technology. Moreover, the COVID-19 pandemic has brought significant traction to the importance of respiratory vaccines which has further accelerated the market.

Respiratory vaccines, particularly those targeting influenza and pneumonia, are vital in reducing the burden on healthcare systems and minimizing the risk of co-infections with COVID-19. In order to prevent the spread of the virus and prevent the occurrence of outbreaks healthcare providers have been focusing on vaccination to protect individuals against respiratory pathogens like influenza. In recent years, the respiratory vaccine market has witnessed substantial growth attributed to advancements in vaccine technology, specifically in the development of vaccines targeting SARS-CoV-2. The successful development, approval, and deployment of COVID-19 vaccines have demonstrated the capacity of the scientific community to respond rapidly to respiratory threats and have paved the way for future advancements in respiratory vaccine research and development.

Moreover, government backing and surveillance at both national and global levels to monitor the availability, dissemination, and implementation of influenza vaccines is a crucial factor driving the growth of the market. Additionally, increased investments by prominent key players with a major focus on the introduction of novel vaccines into the market have contributed to the growth of the market. For instance, Pfizer recently disclosed their plans to commence Phase 3 clinical trials for their mRNA-based influenza vaccine in September 2022. This trial will involve a cohort of 25,000 individuals aged 18 and above from the U.S.

Furthermore, key players involved in developing and formulating various respiratory disease vaccines are focusing on collaborations and partnerships to develop novel vaccines and to maintain their competitive position in the market. In addition, increasing interest in plant-based medicines owing to natural remedies offered by them is expected to boost the market over the forecast period. Moreover, a number of players are involved in geographic expansion and distribution to meet the rising demand for medicinal products. For instance, in May 2023, Pfizer Inc. received FDA approval for ABRYSVO, a RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in the elderly population above the age of 60 years.

Respiratory Disease Vaccine Market Report Highlights

  • Based on type, the viral vaccine segment held the largest revenue share in 2022 owing to the increasing prevalence of viral respiratory conditions
  • Based on age group, the pediatric segment is expected to show the fastest growth rate over the forecast period owing to the rising formulation of vaccines for the pediatric population
  • On the basis of infection, the COVID-19 segment dominated in 2022 due to the growing need for the development of a vaccine to stop the spread of the COVID-19 virus
  • Key players operating in the market are constantly focusing on geographical expansion and product launches to maintain their presence
  • North America held the largest revenue share in 2022 which can be attributed to the presence of key players, rising healthcare infrastructure, growing cases of chronic disorders, and availability of proper vaccination service

Table of Contents

Chapter 1 Respiratory Disease Vaccine Market: Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Definitions
1.1.1.1 Type Segment
1.1.1.2 Age Group Segment
1.1.1.3 Distribution Channel Segment
1.1.1.4 Infection Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 The Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List Of Secondary Sources
1.11 List Of Abbreviations
Chapter 2 Respiratory Disease Vaccine Market: Executive Summary
2.1 Market Snapshot
2.2 Type And Age Group Snapshot
2.3 Distribution Channel And Infection Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Respiratory Disease Vaccine Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Increasing Prevalence Of Respiratory Diseases
3.3.1.2 Growing Awareness And Focus On Prevention
3.3.1.3 Increasing Government Initiatives And Immunization Programs
3.3.1.4 Growing Geriatric Population
3.3.2 Market Restraint Analysis
3.3.2.1 Complex And Time-Consuming Regulatory Approval Process
3.3.2.2 High Price Associated With Vaccines
3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.5 Industry Analysis - Porter’s
3.6 Reimbursement & Regulatory Scenario
3.7 Major Deals & Strategic Alliances
3.7.1 New Product Launch
3.7.2 Acquisition
3.7.3 Expansion
3.7.4 Partnerships
3.7.5 Marketing & Promotions
Chapter 4 Respiratory Disease Vaccine Market: Competitive Landscape
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Company Categorization
4.2.1 Innovators
4.2.1.1 Market Differentiators
4.3 Vendor Landscape
4.3.1 List Of Key Distributors And Channel Partners
4.3.2 Key Customers
4.3.3 Key Company Market Share Analysis, 2022
4.4 Public Companies
4.4.1 Competitive Dashboard Analysis
4.5 Private Companies
4.5.1 List Of Key Emerging Companies
4.6 Regional Network Map
Chapter 5 Respiratory Disease Vaccine Market: Type Business Analysis
5.1 Definition And Scope
5.2 Type Market Share Analysis, 2022 & 2030
5.3 Global Respiratory Disease Vaccine Market, By Type, 2018 To 2030
5.4 Respiratory Disease Vaccine Market: Type Movement Analysis
5.5 Viral Vaccine
5.5.1 Viral Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.6 Bacterial Vaccine
5.6.1 Bacterial Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
5.7 Combination Vaccine
5.7.1 Combination Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Respiratory Disease Vaccine Market: Age Group Business Analysis
6.1 Definition And Scope
6.2 Age Group Market Share Analysis, 2022 & 2030
6.3 Global Respiratory Disease Vaccine Market, By Age Group, 2018 To 2030
6.4 Respiratory Disease Vaccine Market: Age Group Movement Analysis
6.5 Pediatric
6.5.1 Pediatric Market Estimates And Forecast, 2018 - 2030 (USD Million)
6.6 Adult
6.6.1 Adult Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Respiratory Disease Vaccine Market: Infection Business Analysis
7.1 Definition And Scope
7.2 Infection Market Share Analysis, 2022 & 2030
7.3 Global Respiratory Disease Vaccine Market, By Infection, 2018 To 2030
7.4 Respiratory Disease Vaccine Market: Infection Movement Analysis
7.5 Covid-19
7.5.1 Covid-19 Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6 Influenza
7.6.1 Influenza Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7 Respiratory Syncytial Virus (Rsv)
7.7.1 Respiratory Syncytial Virus (Rsv) Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.8 Pneumonia
7.8.1 Pneumonia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.9 Others
7.9.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Respiratory Disease Vaccine Market: Distribution Channel Business Analysis
8.1 Definition And Scope
8.2 Distribution Channel Market Share Analysis, 2022 & 2030
8.3 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 To 2030
8.4 Respiratory Disease Vaccine Market: Distribution Channel Movement Analysis
8.5 Hospital & Retail Pharmacies
8.5.1 Hospital & Retail Pharmacies Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.6 Government Suppliers
8.6.1 Government Suppliers Market Estimates And Forecast, 2018 - 2030 (USD Million)
8.7 Others
8.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 9 Respiratory Disease Vaccine Market: Regional Business Analysis
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
9.5.1 North America
9.5.2 Europe
9.5.3 Asia Pacific
9.5.4 Latin America
9.5.5 MEA
9.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
9.7 North America
9.7.1 North America Respiratory Disease Vaccine Market Estimates And Forecast, 2018 - 2030 (USD Million)
9.7.2 U.S.
9.7.2.1 U.S. Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.7.2.2 Key Country Dynamics
9.7.2.3 Regulatory Framework
9.7.2.4 Competitive Scenario
9.7.3 Canada
9.7.3.1 Canada Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.7.3.2 Key Country Dynamics
9.7.3.3 Regulatory Framework
9.7.3.4 Competitive Scenario
9.8 Europe
9.8.1 Europe Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.2 Uk
9.8.2.1 Uk Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.2.2 Key Country Dynamics
9.8.2.3 Regulatory Framework
9.8.2.4 Competitive Scenario
9.8.3 Germany
9.8.3.1 Germany Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.3.2 Key Country Dynamics
9.8.3.3 Regulatory Framework
9.8.3.4 Competitive Scenario
9.8.4 Spain
9.8.4.1 Spain Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.4.2 Key Country Dynamics
9.8.4.3 Regulatory Framework
9.8.4.4 Competitive Scenario
9.8.5 France
9.8.5.1 France Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.5.2 Key Country Dynamics
9.8.5.3 Regulatory Framework
9.8.5.4 Competitive Scenario
9.8.6 Italy
9.8.6.1 Italy Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.6.2 Key Country Dynamics
9.8.6.3 Regulatory Framework
9.8.6.4 Competitive Scenario
9.8.7 Norway
9.8.7.1 Norway Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.7.2 Key Country Dynamics
9.8.7.3 Regulatory Framework
9.8.7.4 Competitive Scenario
9.8.8 Denmark
9.8.8.1 Denmark Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.8.2 Key Country Dynamics
9.8.8.3 Regulatory Framework
9.8.8.4 Competitive Scenario
9.8.9 Sweden
9.8.9.1 Sweden Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.8.9.2 Key Country Dynamics
9.8.9.3 Regulatory Framework
9.8.9.4 Competitive Scenario
9.9 Asia Pacific
9.9.1 Asia Pacific Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.2 Japan
9.9.2.1 Japan Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.2.2 Key Country Dynamics
9.9.2.3 Regulatory Framework
9.9.2.4 Competitive Scenario
9.9.3 China
9.9.3.1 China Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.3.2 Key Country Dynamics
9.9.3.3 Regulatory Framework
9.9.3.4 Competitive Scenario
9.9.4 India
9.9.4.1 India Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.4.2 Key Country Dynamics
9.9.4.3 Regulatory Framework
9.9.4.4 Competitive Scenario
9.9.5 South Korea
9.9.5.1 South Korea Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.5.2 Key Country Dynamics
9.9.5.3 Regulatory Framework
9.9.5.4 Competitive Scenario
9.9.6 Thailand
9.9.6.1 Thailand Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.6.2 Key Country Dynamics
9.9.6.3 Regulatory Framework
9.9.6.4 Competitive Scenario
9.9.7 Australia
9.9.7.1 Australia Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.9.7.2 Key Country Dynamics
9.9.7.3 Regulatory Framework
9.9.7.4 Competitive Scenario
9.10 Latin America
9.10.1 Latin America Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.10.2 Brazil
9.10.2.1 Brazil Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.10.2.2 Key Country Dynamics
9.10.2.3 Regulatory Framework
9.10.2.4 Competitive Scenario
9.10.3 Mexico
9.10.3.1 Mexico Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.10.3.2 Key Country Dynamics
9.10.3.3 Regulatory Framework
9.10.3.4 Competitive Scenario
9.10.4 Argentina
9.10.4.1 Argentina Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.10.4.2 Key Country Dynamics
9.10.4.3 Regulatory Framework
9.10.4.4 Competitive Scenario
9.11 MEA
9.11.1 MEA Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.11.2 South Africa
9.11.2.1 South Africa Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.11.2.2 Key Country Dynamics
9.11.2.3 Regulatory Framework
9.11.2.4 Competitive Scenario
9.11.3 Saudi Arabia
9.11.3.1 Saudi Arabia Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.11.3.2 Key Country Dynamics
9.11.3.3 Regulatory Framework
9.11.3.4 Competitive Scenario
9.11.4 UAE
9.11.4.1 UAE Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.11.4.2 Key Country Dynamics
9.11.4.3 Regulatory Framework
9.11.4.4 Competitive Scenario
9.11.5 Kuwait
9.11.5.1 Kuwait Respiratory Disease Vaccine Market, 2018 - 2030 (USD Million)
9.11.5.2 Key Country Dynamics
9.11.5.3 Regulatory Framework
9.11.5.4 Competitive Scenario
Chapter 10 Respiratory Disease Vaccine Market: Company Profiling
10.1 Company Categorization
10.2 Strategy Mapping
10.2.1 New Product Launch
10.2.2 Partnerships
10.2.3 Acquisition
10.2.4 Collaboration
10.2.5 Funding
10.3 Key Company Market Share Analysis, 2022
10.4 Company Profiles
10.4.1 Gsk Plc.
10.4.1.1 Company Overview
10.4.1.2 Financial Performance
10.4.1.3 Product Benchmarking
10.4.1.4 Strategic Initiatives
10.4.2 Johnson & Johnson Services, Inc.
10.4.2.1 Company Overview
10.4.2.2 Financial Performance
10.4.2.3 Product Benchmarking
10.4.2.4 Strategic Initiatives
10.4.3 Pfizer Inc.
10.4.3.1 Company Overview
10.4.3.2 Financial Performance
10.4.3.3 Product Benchmarking
10.4.3.4 Strategic Initiatives
10.4.4 Sanofi
10.4.4.1 Company Overview
10.4.4.2 Financial Performance
10.4.4.3 Product Benchmarking
10.4.4.4 Strategic Initiatives
10.4.5 Serum Institute Of India Pvt. Ltd.
10.4.5.1 Company Overview
10.4.5.2 Product Benchmarking
10.4.5.3 Strategic Initiatives
10.4.6 Sinovac
10.4.6.1 Company Overview
10.4.6.2 Product Benchmarking
10.4.6.3 Strategic Initiatives
10.4.7 Bavarian Nordic
10.4.7.1 Company Overview
10.4.7.2 Financial Performance
10.4.7.3 Product Benchmarking
10.4.7.4 Strategic Initiatives
10.4.8 Merck & Co., Inc.
10.4.8.1 Company Overview
10.4.8.2 Financial Performance
10.4.8.3 Product Benchmarking
10.4.8.4 Strategic Initiatives
10.4.9 Astrazeneca
10.4.9.1 Company Overview
10.4.9.2 Financial Performance
10.4.9.3 Product Benchmarking
10.4.9.4 Strategic Initiatives
10.4.10 Emergent
10.4.10.1 Company Overview
10.4.10.2 Financial Performance
10.4.10.3 Product Benchmarking
10.4.10.4 Strategic Initiatives
10.4.11 Novavax
10.4.11.1 Company Overview
10.4.11.2 Financial Performance
10.4.11.3 Product Benchmarking
10.4.11.4 Strategic Initiatives
10.4.12 Inovio Pharmaceuticals
10.4.12.1 Company Overview
10.4.12.2 Financial Performance
10.4.12.3 Product Benchmarking
10.4.12.4 Strategic Initiatives
10.4.13 Moderna Inc.
10.4.13.1 Company Overview
10.4.13.2 Financial Performance
10.4.13.3 Product Benchmarking
10.4.13.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Respiratory Disease Vaccine Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 5 Global Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 6 Global Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 7 Global Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 8 North America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 10 North America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 11 North America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 12 North America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 13 U.S. Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 14 U.S. Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 15 U.S. Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 16 U.S. Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 17 Canada Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 18 Canada Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 19 Canada Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 20 Canada Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 21 Europe Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 22 Europe Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 23 Europe Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 24 Europe Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 25 Europe Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Germany Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 27 Germany Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 28 Germany Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 29 Germany Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 30 UK Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 31 UK Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 32 UK Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 33 UK Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 34 France Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 35 France Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 36 France Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 37 France Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Italy Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 39 Italy Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 40 Italy Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 41 Italy Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Spain Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 43 Spain Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 44 Spain Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 45 Spain Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Denmark Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 47 Denmark Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 48 Denmark Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 49 Denmark Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 50 Sweden Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 51 Sweden Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 52 Sweden Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 53 Sweden Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 54 Norway Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 55 Norway Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 56 Norway Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 57 Norway Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Japan Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 64 Japan Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 65 Japan Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 66 Japan Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 67 China Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 68 China Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 69 China Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 70 China Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 71 India Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 72 India Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 73 India Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 74 India Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 75 South Korea Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 76 South Korea Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 77 South Korea Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 78 South Korea Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Australia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 80 Australia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 81 Australia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 82 Australia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 83 Thailand Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 84 Thailand Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 85 Thailand Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 86 Thailand Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 87 Latin America Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 88 Latin America Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 89 Latin America Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 90 Latin America Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 91 Latin America Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Brazil Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 93 Brazil Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 94 Brazil Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 95 Brazil Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 96 Mexico Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 97 Mexico Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 98 Mexico Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 99 Mexico Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 100 Argentina Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 101 Argentina Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 102 Argentina Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 103 Argentina Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Respiratory Disease Vaccine Market, By Country, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 108 Middle East & Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 111 Saudi Arabia Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 113 South Africa Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 114 South Africa Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 115 South Africa Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 116 South Africa Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 117 UAE Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 118 UAE Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 119 UAE Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 120 UAE Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 121 Kuwait Respiratory Disease Vaccine Market, By Type, 2018 - 2030 (USD Million)
Table 122 Kuwait Respiratory Disease Vaccine Market, By Age Group, 2018 - 2030 (USD Million)
Table 123 Kuwait Respiratory Disease Vaccine Market, By Infection, 2018 - 2030 (USD Million)
Table 124 Kuwait Respiratory Disease Vaccine Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Respiratory Disease Vaccine Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Respiratory disease vaccine market: Type outlook and key takeaways
Fig. 15 Respiratory disease vaccine market: Type movement analysis & market share 2022 & 2030
Fig. 16 Viral vaccines market, 2018 - 2030 (USD Million)
Fig. 17 Bacterial vaccine market, 2018 - 2030 (USD Million)
Fig. 18 Combination vaccine market, 2018 - 2030 (USD Million)
Fig. 19 Respiratory disease vaccine market: Age group outlook and key takeaways
Fig. 20 Respiratory disease vaccine market: Age group movement analysis & market share 2022 & 2030
Fig. 21 Pediatric market, 2018 - 2030 (USD Million)
Fig. 22 Adult market, 2018 - 2030 (USD Million)
Fig. 23 Respiratory disease vaccine market: Infection outlook and key takeaways
Fig. 24 Respiratory disease vaccine market: Infection movement analysis & market share 2022 & 2030
Fig. 25 COVID-19 market, 2018 - 2030 (USD Million)
Fig. 26 Influenza market, 2018 - 2030 (USD Million)
Fig. 27 Respiratory syncytial virus (RSV) market, 2018 - 2030 (USD Million)
Fig. 28 Pneumonia market, 2018 - 2030 (USD Million)
Fig. 29 Others antifungal drugs market, 2018 - 2030 (USD Million)
Fig. 30 Respiratory disease vaccine market: Distribution channel outlook and key takeaways
Fig. 31 Respiratory disease vaccine market: Distribution channel movement analysis & market share 2022 & 2030
Fig. 32 Hospital & retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Government suppliers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Regional Marketplace: Key Takeaways
Fig. 36 Regional Outlook, 2022 & 2030
Fig. 37 Regional Market Dashboard
Fig. 38 Regional Market Place: Key Takeaways
Fig. 39 North America, SWOT Analysis
Fig. 40 Europe, SWOT Analysis
Fig. 41 Asia Pacific, SWOT Analysis
Fig. 42 Latin America, SWOT Analysis
Fig. 43 MEA, SWOT Analysis
Fig. 44 North America
Fig. 45 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 46 U.S. Key Country Dynamics
Fig. 47 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 48 Canada Key Country Dynamics
Fig. 49 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 50 Europe
Fig. 51 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 52 UK Key Country Dynamics
Fig. 53 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 54 Germany Key Country Dynamics
Fig. 55 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 56 France Key Country Dynamics
Fig. 57 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 58 Italy Key Country Dynamics
Fig. 59 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 60 Spain Key Country Dynamics
Fig. 61 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 62 Denmark Key Country Dynamics
Fig. 63 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 64 Sweden Key Country Dynamics
Fig. 65 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 66 Norway Key Country Dynamics
Fig. 67 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 68 Asia Pacific Key Country Dynamics
Fig. 69 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 70 Japan Key Country Dynamics
Fig. 71 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 72 China Key Country Dynamics
Fig. 73 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 74 India
Fig. 75 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 76 Australia Key Country Dynamics
Fig. 77 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 78 Thailand Key Country Dynamics
Fig. 79 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 80 South Korea Key Country Dynamics
Fig. 81 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 82 Latin America
Fig. 83 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 84 Brazil Key Country Dynamics
Fig. 85 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 86 Mexico Key Country Dynamics
Fig. 87 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 88 Argentina Key Country Dynamics
Fig. 89 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 90 MEA
Fig. 91 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 92 South Africa Key Country Dynamics
Fig. 93 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 94 Saudi Arabia Key Country Dynamics
Fig. 95 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 96 UAE Key Country Dynamics
Fig. 97 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 98 Kuwait Key Country Dynamics
Fig. 99 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 100 Strategy Mapping

Companies Mentioned

  • Gsk Plc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute Of India Pvt. Ltd.
  • Sinovac
  • Bavarian Nordic
  • Merck & Co., Inc.
  • Astrazeneca
  • Emergent
  • Novavax
  • Inovio Pharmaceuticals
  • Moderna Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Respiratory Disease Vaccine Market by Infection, Type, Age Group - Global Forecast 2025-2030 - Product Image

Respiratory Disease Vaccine Market by Infection, Type, Age Group - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Respiratory Disease Vaccine Global Market Report 2024 - Product Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 181 Pages
  • Global
From
COVID-19 Vaccines Market by Product Type, End-User, Patient Type - Global Forecast 2025-2030 - Product Image

COVID-19 Vaccines Market by Product Type, End-User, Patient Type - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
COVID-19 Vaccines - Global Strategic Business Report - Product Image

COVID-19 Vaccines - Global Strategic Business Report

  • Report
  • 762 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.